Mast Cell Protease 4 Activators
Mast Cell Protease 4 (MCP-4) Activators encompass a range of chemical compounds that indirectly augment MCP-4's functional activity by influencing mast cell dynamics and related signaling pathways. Cromolyn Sodium and Nedocromil, both mast cell stabilizers, enhance MCP-4 activity by keeping mast cells in a primed state, ready for activation. This preparation ensures an efficient release of MCP-4 upon appropriate stimulation. Similarly, Ketotifen and Quercetin, through their mast cell stabilizing and anti-histamine properties, control MCP-4 activity by managing the degranulation process of mast cells, thereby dictating the functional dynamics of MCP-4. In this context, Famotidine and Ranitidine, as H2 histamine receptor antagonists, also play a significant role by modulating histamine signaling, which in turn influences MCP-4 release by altering mast cell responsiveness.
Further influencing the activity of MCP-4 are compounds like Zafirlukast and Montelukast, leukotriene receptor antagonists that adjust the leukotriene-mediated signaling environment within tissues. This adjustment can enhance MCP-4 activity by altering the inflammatory milieu where mast cells and MCP-4 are active. Omalizumab, an anti-IgE antibody, indirectly increases MCP-4 activity by modulating mast cell activation thresholds through its binding to IgE. This modulation affects the dynamics of MCP-4 release. Additionally, Ibudilast and Epinephrine, by increasing cAMP levels and stabilizing mast cells through adrenergic receptor activation respectively, further contribute to the regulation of MCP-4 activity. Azelastine, an antihistamine, also indirectly impacts MCP-4 through its effects on mast cell activation and degranulation dynamics. Collectively, these activators work in concert to finely tune the release and functional activity of MCP-4 in physiological and pathophysiological processes without directly interacting with the protease itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cromolyn disodium salt | 15826-37-6 | sc-207459 sc-207459A sc-207459B sc-207459C sc-207459D sc-207459E sc-207459F | 1 g 5 g 25 g 50 g 100 g 500 g 1 kg | $50.00 $174.00 $624.00 $1040.00 $1873.00 $2913.00 $3537.00 | ||
Cromolyn Sodium stabilizes mast cells, preventing degranulation. This action indirectly enhances Mast Cell Protease 4 activity by maintaining a ready state in mast cells, which allows for rapid response and release of Mast Cell Protease 4 upon appropriate stimulation. | ||||||
Zafirlukast | 107753-78-6 | sc-204942 sc-204942A | 10 mg 100 mg | $37.00 $174.00 | 1 | |
Zafirlukast, a leukotriene receptor antagonist, modulates leukotriene activity. This modulation indirectly supports Mast Cell Protease 4 activity by altering the leukotriene-mediated signaling environment in tissues where mast cells are active, thereby potentially enhancing the functional response of Mast Cell Protease 4. | ||||||
Ibudilast | 50847-11-5 | sc-203080 | 10 mg | $218.00 | 1 | |
Ibudilast, a phosphodiesterase inhibitor, increases cAMP levels. Elevated cAMP in mast cells can indirectly enhance Mast Cell Protease 4 activity by influencing mast cell stabilization and response dynamics. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid with mast cell stabilizing properties, can indirectly enhance Mast Cell Protease 4 activity by reducing mast cell degranulation, thus controlling the release and functional dynamics of Mast Cell Protease 4. | ||||||
Famotidine | 76824-35-6 | sc-205691 sc-205691A | 500 mg 1 g | $65.00 $111.00 | ||
Famotidine, an H2 histamine receptor antagonist, modulates histamine signaling. This modulation can indirectly influence Mast Cell Protease 4 activity by altering mast cell responsiveness and thus the dynamics of Mast Cell Protease 4 release. | ||||||
Azelastine | 58581-89-8 | sc-337544 sc-337544A sc-337544B | 100 mg 500 mg 1 g | $220.00 $550.00 $700.00 | ||
Azelastine, an antihistamine, by impacting histamine receptor signaling, can indirectly influence Mast Cell Protease 4 activity through its effects on mast cell activation and degranulation dynamics. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, through its action on adrenergic receptors, can stabilize mast cells. This stabilization indirectly enhances Mast Cell Protease 4 activity by modulating the activation threshold and release mechanisms of mast cells. | ||||||
Ranitidine | 66357-35-5 | sc-203679 | 1 g | $193.00 | ||
Ranitidine, another H2 histamine receptor antagonist, alters histamine signaling pathways. This alteration can indirectly influence Mast Cell Protease 4 activity by modulating the responsiveness of mast cells, which are integral to the release of Mast Cell Protease 4. | ||||||